Thomas F. Gajewski M.D., Ph.D.
Co-founder & SAB Chair
Tom is a Professor in the Departments of Pathology, Medicine, and the Ben May Cancer Institute at the University of Chicago. Tom is a pioneer in the field of cancer immunotherapy with more than 200 publications. In the biotech industry, he co-founded Jounce (NASDAQ: JNCE) and was a licensee and a SAB member of Evelo Biosciences Inc. (NASDAQ: EVLO) and Aduro BioTech Inc. (NASDAQ: ADRO).
Tom served as President of the Society for Immunotherapy of Cancer (SITC) and he has been a recipient of many awards including American Cancer Society-Jules L. Plangere Jr. Family Foundation Professorship in Cancer Immunotherapy, the Outstanding Investigator Award by NIH and the Giants of Cancer Care for 2017 by OncLive®. He received his medical training, Ph.D. in Immunology and B.A. at the University of Chicago.